Glimsentro-PG2 Tablet SR

Glimsentro-PG2 Tablet SR
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Glynet-PM2 Tablet ER
Zeelab Pharmacy Pvt Ltd
Pioglitazone 15mgPack Size
1 units
Price
Save ₹131
that's 85% off!
About This Medicine
Product description & overview
Glimsentro-PG2 Tablets SR: A Comprehensive Treatment Option
Glimsentro-PG2 Tablets SR is a combination medication containing Glimepiride, Metformin, and Pioglitazone. This innovative tablet formulation combines three key medications for effective management of type 2 diabetes mellitus (T2DM).
* Glimepiride: A selective sulfonylurea receptor agonist that helps regulate blood glucose levels by stimulating insulin secretion.
* Metformin: A biguanide with multiple mechanisms, primarily targeting hepatic glucose production and increasing peripheral glucose uptake.
* Pioglitazone: A thiazolidinedione that enhances insulin sensitivity in muscle and fat tissues to improve blood glucose control.
The combination of these medications provides a comprehensive approach to T2DM management, offering:
* Improved glycemic control: Achieving better blood sugar regulation through synergistic effects of the individual agents.
* Synergistic action: Enhanced efficacy compared to single-medication therapy due to their combined effect.
* Comprehensive treatment: Addressing multiple aspects of insulin resistance and glucose metabolism.
Note: Always consult your healthcare professional before starting or changing any medication regimen.
This description is for informational purposes only and does not constitute medical advice.
Active composition
Glimepiride 2 mg
+2 more active ingredients
About Glimepiride
Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
All Active Ingredients
Pioglitazone
Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-γ), enhancing insulin sensitivity and glucose metabolism.
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Glimsentro-PG2 Tablet SR.
High Risk
Pregnancy
Glimsentro-PG2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Glimsentro-PG2 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glimsentro-PG2 Tablet SR may be needed. Please consult your doctor. Use of Glimsentro-PG2 Tablet SR is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Glimsentro-PG2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Glimsentro-PG2 Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Glimsentro-PG2 Tablet SR may be needed. Please consult your doctor. Use of Glimsentro-PG2 Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Regular Checkup
Customer Reviews
0 reviews for Glimsentro-PG2 Tablet SR
Products matching your search

Maxpride 200 Tablet

Maxpride 200 Tablet

Heximar-B Ointment

Heximar-B Ointment

Glimicer 1mg Tablet

Glimicer 1mg Tablet

Joypride 200mg Tablet

Joypride 200mg Tablet

Luramax 40 Tablet

Luramax 40 Tablet

Gillyvor-D Capsule SR

Gillyvor-D Capsule SR

Etorica 60mg Tablet

Etorica 60mg Tablet

Gixmin 400mg Tablet
